Stay updated on MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial
Sign up to get notified when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.

Latest updates to the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page
- Check3 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision history updated: added Revision v3.5.0 and removed Revision v3.4.3.SummaryDifference0.1%

- Check25 days agoChange DetectedThe page revision label was updated from v3.4.2 to v3.4.3, replacing the previous version.SummaryDifference0.1%

- Check54 days agoChange DetectedThe page now shows Revision: v3.4.2, replacing v3.4.1, indicating a platform update with no substantive changes to study information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check61 days agoChange DetectedRevision updated from v3.4.0 to v3.4.1.SummaryDifference0.1%

- Check68 days agoChange DetectedShow glossary was added and labels were updated to 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data' with standardized capitalization. 'Revision: v3.4.0' was added and 'Revision: v3.3.4' was removed.SummaryDifference0.2%

- Check82 days agoChange DetectedRevision: v3.3.4 added, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the MG1-MAGEA3 Combo with Pembrolizumab for NSCLC Clinical Trial page.